The co-localization of PDGFC- PDGFRA interaction with fibrotic areas and markers was notably more pronounced in slides obtained from MASH patients with fibrosis stage 3 and 4 scores, compared to healthy samples or those with fibrosis stage 1 and 2 scores. This evidence concerns the gene PDGFRA and metabolic dysfunction-associated steatohepatitis.